Totally agree. There are many people who get massive results with finasteride+min. Plus, they get decent hair transplant and maintain their norwood many many years.I don't get the attitude of, oh ,it's just another finasteride and minoxidil. Scroll through Tressless at any given time and you'll see people make massive gains with those drugs. Maybe you'll be a hyperresponder to this drug like they are to those and if not, maybe the effect is additive. Of course, that's all presuming the price isn't astronomical, but as someone already said, if the effect isn't like in the monkeys, then they'll have to cut the price down, too (if the cost of production permits).
I don't get it, how stupid someone have to be to totally ignore the fact that minoxdil not-responders exist. And that some people can't tolerate (even) finasteride because of side effects.
"I have seen people on tressless with better results on finasteride/min only"
But you haven't seen thousands of Minoxidil not-responders / Finasteride-limp-dick-blessed guys who has nothing to brag about and are waiting for some other options.
Even if these were the average result of the treatment - I would not be disappointed. And as far as I know macaques were getting regrowth many months after the treatment has finished.
Also, estimating efficiency from one (n=1) anonymous user (Reddit Medical Database inc.) is just... Just wait for the phase II results.
Sorry, for my english, I am not native speaker, haven't logged for years here. Let as pray that this is not another "Brotzu loti
Go team erectile dysfunction, Go! Go erectile dysfunction it's your birthday, Go!I would love to have a chance to pick sides aside from the ones Finasteride gives me.
What difference? N=1 doesn't tell us anything.This is so dissapointing. Compared to the Monkeys nearly nothing
Maybe Good for maintenance.
@Pegasus you Said that macques have the same hair loss like People. How do you think about the differences of HMI-115 now?
He has very little improvement. That is.
This is so dissapointing. Compared to the Monkeys nearly nothing![]()
Maybe Good for maintenance.
@Pegasus you Said that macques have the same hair loss like People. How do you think about the differences of HMI-115 now?
Is it a single or multi center study? If multi could be he hasn't seen all the participants. Still bad, but not as bad.Unfortunately the clinical investigators Said to this Moeman that he was the best responder…
The drug shows a higher affinity for hPRLR. The dose is the same in phase II, so they believe the dose is sufficient too. Macaques have a much shorter hair cycle, and that could affect how long it takes to respond. It's possible that miniaturization can only be reversed during early anagen.HairLossTalk.com community is so depressive... So, what people do not see here, apart from the evident regrowth in a clinical phase whose main objective is not to assess effectivenes and dosage, but rather check efficacy and safety, is that it's being proven that the PRLR is really linked to Androgenetic Alopecia.
It might be that the antibody shows higher affinity to the monekys PRLR than for humans. It might be that the dosage is too low for humans. It might be a matter of the timespan of hair cycles... Only for HMI there is a lot to be researched.
But more importantly, this opens new research lines for new products based on silencing the PRLR, because, let's be clear, a monoclonal antibody is not very likely to be very marketable as a treatment for a (for many) cosmetical issue.
I think there were 2 CenterIs it a single or multi center study? If multi could be he hasn't seen all the participants. Still bad, but not as bad.
Yeah like I said I was under the impression you had to retrial different drug vehicles, but Rassman said 13 days ago that for Amplifica they're doing injections for its human trials but releasing it commercially as a cream or topical if the trials are successful. So maybe there's some exception I'm not aware of in this case that lets them skip that step.A topical version of HMI would probably need its own set of clinical trials.
Is it a single or multi center study? If multi could be he hasn't seen all the participants. Still bad, but not as bad.
